Breakthrough Chemistry, Inc. (BKTH)
0.095
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Breakthrough Chemistry Enterprise Value : 0.2897M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.2897M |
| October 08, 2026 | 0.2897M |
| October 07, 2026 | 0.4064M |
| October 06, 2026 | 0.4055M |
| October 05, 2026 | 0.4055M |
| October 02, 2026 | 0.4055M |
| October 01, 2026 | 0.36M |
| September 30, 2026 | 0.8005M |
| September 29, 2026 | 0.241M |
| September 28, 2026 | 0.2897M |
| September 25, 2026 | 0.2897M |
| September 24, 2026 | 0.2381M |
| September 23, 2026 | 0.2381M |
| September 22, 2026 | 0.2381M |
| September 21, 2026 | 0.2381M |
| September 18, 2026 | 0.0542M |
| September 17, 2026 | 1.214M |
| September 16, 2026 | 0.6886M |
| September 15, 2026 | 1.506M |
| September 14, 2026 | 1.506M |
| September 11, 2026 | 1.506M |
| September 10, 2026 | 1.506M |
| September 09, 2026 | 1.506M |
| September 08, 2026 | 1.389M |
| September 04, 2026 | 1.389M |
| Date | Value |
|---|---|
| September 03, 2026 | 1.389M |
| September 02, 2026 | 1.389M |
| September 01, 2026 | 1.389M |
| August 31, 2026 | 1.389M |
| August 28, 2026 | 1.389M |
| August 27, 2026 | 1.389M |
| August 26, 2026 | 1.389M |
| August 25, 2026 | 1.389M |
| August 24, 2026 | 1.389M |
| August 21, 2026 | 1.389M |
| August 20, 2026 | 1.389M |
| August 19, 2026 | 1.389M |
| August 18, 2026 | 1.243M |
| August 17, 2026 | 1.243M |
| August 14, 2026 | 1.172M |
| August 13, 2026 | 1.206M |
| August 12, 2026 | 1.196M |
| August 11, 2026 | 1.408M |
| August 10, 2026 | 1.408M |
| August 07, 2026 | 1.506M |
| August 06, 2026 | 1.931M |
| August 05, 2026 | 1.966M |
| August 04, 2026 | 1.966M |
| August 03, 2026 | 1.966M |
| July 31, 2026 | 1.966M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cardiac Biotech Solutions, Inc. | 6.491M |
| Precision Optics Corp., Inc. | 44.48M |
| Petros Pharmaceuticals, Inc. | -3.347M |
| RxSight, Inc. | 1.807M |
| Vyome Holdings, Inc. | 8.062M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.083M |
| Revenue (Quarterly) | 0.0025M |
| Total Expenses (Quarterly) | 1.085M |
| EPS Diluted (Quarterly) | -0.1113 |
| Profit Margin (Quarterly) | -43.31K% |
| Earnings Yield | -107.1% |
| Normalized Earnings Yield | -36.63 |